Evidence map›Paper›PMID 36814897›Full record

ArticleJournal of migration and health2023

Migrants' access to COVID-19 vaccination in Japan: Progress and challenges.

Masami Fujita, Miwa Kanda, Hiroyuki Kiyohara, Saki Ikeda, Azusa Iwamoto, Kyoko Sudo, Yuko Teshima, Midori Nii, Yoji Murata, Jotaro Kato and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of migration and health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Masami FujitaBureau of International Health Cooperation, National Center for Global Health and Medicine (NCGM), Japan.
Miwa KandaBureau of International Health Cooperation, National Center for Global Health and Medicine (NCGM), Japan.
Hiroyuki KiyoharaBureau of International Health Cooperation, National Center for Global Health and Medicine (NCGM), Japan.
Saki IkedaBureau of International Health Cooperation, National Center for Global Health and Medicine (NCGM), Japan.
Azusa IwamotoBureau of International Health Cooperation, National Center for Global Health and Medicine (NCGM), Japan.
Kyoko SudoBureau of International Health Cooperation, National Center for Global Health and Medicine (NCGM), Japan.
Yuko TeshimaMigrants' Neighbor Network & Action (MINNA), Tokyo, Japan.
Midori NiiCitizen's Network for Global Activities (CINGA), Japan.
Yoji MurataBureau of Citizens and Cultural Affairs, Tokyo Metropolitan Government, Japan.
Jotaro KatoWaseda University, Japan.
Aiko KomatsuMigrants' Neighbor Network & Action (MINNA), Tokyo, Japan.
Aya YuminoMigrants' Neighbor Network & Action (MINNA), Tokyo, Japan.
Takashi SawadaMigrants' Neighbor Network & Action (MINNA), Tokyo, Japan.
Hiroshi SatoMigrants' Neighbor Network & Action (MINNA), Tokyo, Japan.
Tamotsu NakasaMigrants' Neighbor Network & Action (MINNA), Tokyo, Japan.
National Center for Global Health and Medicine · JPThe University of Tokyo · JPCitizen (Japan) · JPJapan External Trade Organization · JPNagasaki University · JPTokyo Metropolitan Government · JPWaseda University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to review the progress and challenges of COVID-19 vaccine roll-out for migrants in Japan and discuss the approaches to address the challenges and better prepare for future waves of COVID-19 and other pandemics. Methods: We conducted a literature review using an assessment framework which we developed building upon existing frameworks and tools on access to health services and COVID-19 vaccination among migrants. Results: COVID-19 vaccination coverage among foreigners might be lower than that of nationals although the data on foreigners were not widely available. A gap appeared to exist between the government's efforts to disseminate vaccine-related information through multi-lingual websites and migrant communities as recipients. A series of barriers for migrants were identified at different stages of the vaccination process. While efforts were made by different units of local governments, NGOs, migrant communities, and international exchange associations, linkages across sectors and scaling-up appeared to be an issue. No foreigners were explicitly excluded from the entitlements of COVID-19 vaccination. The national level guidance, however, allowed sub-national levels to make a decision on whether or not undocumented foreigners should be reported to the immigration office or law enforcement when providing the services. In consequence, units in charge of public health and vaccination of some municipalities did not offer vaccination to those in need. Conclusion: Migrants, especially those unregistered face various barriers in accessing COVID-19 vaccination. It is critical to assess and address challenges concerning channels of information dissemination, pathways to access services, obstacles for vulnerable migrants, and data for evidence-based actions.

Indexed as

Access to informationBarriers/facilitators to vaccinationCOVID-19 vaccineEntitlementInclusionMigrants

Identifiers

PMID36814897
PMCPMC9932756
OpenAlexW4321113882

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.